Cellular Matrix Skin — autologous PRP + hyaluronic acid, prepared chairside in a closed circuit, for facial and dermatological biostimulation. Single session. CE-marked.
Request clinical documentation or distributor information for your region.
Cellular Matrix Skin is RegenLab’s autologous PRP-and-hyaluronic-acid preparation for the face and skin. Made chairside in a closed circuit and used in a single session, it gives aesthetic and dermatology practitioners a biostimulation option that draws on the patient’s own biology.
Ask any aesthetic or dermatology practice what patients are asking for, and the answer is increasingly the same: visibly healthier skin — more even, better hydrated, firmer — without downtime and without the “done” look of heavier interventions. The tools on hand rarely land in that sweet spot. Topical regimens act slowly and only at the surface, and depend entirely on the patient keeping them up. At the other end, ablative resurfacing, surgery and volumising fillers deliver change, but with recovery time and a shift in appearance that many people actively want to avoid. What tends to be missing is a middle path: an approach that improves the quality of the skin itself, gradually and from within, by supporting the tissue’s own repair processes rather than layering product on top or cutting into it. Autologous biostimulation is designed for precisely that middle ground.
The logic of pairing the two components comes down to what each does in the dermis. Concentrated autologous platelets carry growth factors that, once released into the tissue, take part in the skin’s natural biostimulation and repair signalling. Hyaluronic acid — already native to the dermis — brings immediate hydration and viscoelastic support, and doubles as a carrier that helps keep the platelet concentrate where it is placed. On their own each has limits; delivered together in a set, controlled proportion, they reinforce one another. What makes the pairing dependable is the closed device itself: rather than a practitioner blending plasma and HA freehand, the system produces the same ratio every time, which is what lets one clinician’s preparation resemble another’s. The result is a single autologous product, made and used in one sitting.
In practice, Cellular Matrix Skin is prepared and applied within the same appointment, with nothing sent to an outside laboratory. The clinician draws a small volume of the patient’s blood straight into the single-use device, then runs one centrifugation cycle that separates the plasma and blends it with hyaluronic acid inside the sealed tube. Nothing is decanted, pipetted or combined by hand. The finished autologous preparation is applied across the chosen areas — commonly the face, neck, décolleté or backs of the hands — before the patient leaves. Keeping the whole process inside a closed, disposable circuit is deliberate: it removes the open-handling steps where sterility and consistency are most easily lost, and it lets the technique slot into an ordinary aesthetic consultation rather than demanding cell-processing equipment or a dedicated cleanroom. Detailed preparation and injection protocols are set out on the product page.
For platelet-based treatments, the published record is only as meaningful as the consistency of the preparation behind it — a product that varies makes results hard to attribute. Because the closed system fixes the platelet-to-hyaluronic-acid ratio, every preparation starts from the same baseline, session after session and clinician after clinician. RegenLab’s technologies are supported by a substantial body of independent, peer-reviewed work, including publications in aesthetic and dermatological settings that practitioners can weigh when deciding whether the approach suits their patients. We don’t restate individual trial outcomes here; instead, the science hub collects the relevant references in one place, so they can be read in full and against the specific claims each market authorises. Anyone evaluating Cellular Matrix Skin should review both that literature and the regulatory file that applies in their own region before adopting it.
It is an autologous preparation that combines platelet-rich plasma with hyaluronic acid in one closed-circuit step, rather than PRP alone.
Facial and skin-quality biostimulation, extending to the neck, décolleté and hands.
Yes — preparation and application happen in the same visit, with no external lab step and no dedicated cell-processing setup.
Yes, under the EU Medical Device Regulation (MDR).
Through the contact form; our team connects you with the distributor for your region.